Stephen D Silberstein (Stephen Silberstein, Stephan D Silberstein)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 27

Top Venues

Cephalalgia : an international journal of headache

Expert review of neurotherapeutics

The journal of headache and pain

Headache

Thomas Jefferson University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Thomas Jefferson University Jul 01 1999

United States

Prof :: Neurology

Publications

Patricia Pozo-Rosich, Alicia Alpuente, Stephen D Silberstein, Rami Burstein
Insights from 25 years of onabotulinumtoxinA in migraine - mechanisms and management. Nature reviews. Neurology (2024)
Sawsan Alabbad, Nathalia Figueredo, Hsiangkuo Yuan, Stephen D Silberstein
Developments in targeting calcitonin gene-related peptide. Expert review of neurotherapeutics (2024)
Sawsan Alabbad, Nathalia Figueredo, Hsiangkuo Yuan, Stephen D Silberstein
Developments in targeting calcitonin gene-related peptide. Expert review of neurotherapeutics 24 (5) (2024)
Patricia Pozo-Rosich, Alicia Alpuente, Stephen D Silberstein, Rami Burstein
Insights from 25 years of onabotulinumtoxinA in migraine - mechanisms and management. Nature reviews. Neurology 20 (9) (2024)
Sawsan Alabbad, Nathalia Figueredo, Hsiangkuo Yuan, Stephen D Silberstein
Developments in targeting calcitonin gene-related peptide. Expert review of neurotherapeutics 24 (5) (2024)
Thomas Berk, Stephen D Silberstein, Peter McAllister
A Novel Virtual-Based Comprehensive Clinical Approach to Headache Care. Journal of clinical medicine 12 (16) (2023)
Fred Cohen, Hsiangkuo Yuan, Stephen D Silberstein
Calcitonin Gene-Related Peptide (CGRP)-Targeted Monoclonal Antibodies and Antagonists in Migraine: Current Evidence and Rationale. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 36 (3) (2022)
Hans-Christoph Diener, Peter McAllister, Tim P Jürgens, Yoel Kessler, Xiaoping Ning, Joshua M Cohen, Verena Ramirez Campos, Steve Barash, Stephen D Silberstein
Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies. Cephalalgia : an international journal of headache 42 (8) (2022)
Stephen D Silberstein, Shoshana Reshef, Joshua M Cohen, Sanjay Gandhi, Michael Seminerio, Verena Ramirez Campos, Yoel Kessler, Stephen F Thompson, Andrew Blumenfeld
Adverse Events Reported with Therapies Targeting the CGRP Pathway During the First 6 Months Post-launch: A Retrospective Analysis Using the FDA Adverse Events Reporting System. Advances in therapy (2022)
Todd J Schwedt, Cristina Tassorelli, Stephen D Silberstein, Christina L Szperka, Tobias Kurth, Patricia Pozo-Rosich, Faisal Mohammad Amin, Richard B Lipton, David W Dodick, Messoud Ashina, Hans-Christoph Diener, Gisela M Terwindt
Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1 st edition. Cephalalgia : an international journal of headache 42 (11-12) (2022)
Susan Hutchinson, Stephen D Silberstein, Andrew M Blumenfeld, Richard B Lipton, Kaifeng Lu, Sung Yun Yu, Lawrence Severt
Safety and efficacy of ubrogepant in participants with major cardiovascular risk factors in two single-attack phase 3 randomized trials: ACHIEVE I and II. Cephalalgia : an international journal of headache 41 (9) (2021)
Stephen D Silberstein, Joshua M Cohen, Ronghua Yang, Sanjay K Gandhi, Evelyn Du, Adelene E Jann, Michael J Marmura
Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trials. The journal of headache and pain 22 (1) (2021)
Vimala N Bharadwaj, Frank Porreca, Robert P Cowan, Shashidhar Kori, Stephen D Silberstein, David C Yeomans
A new hypothesis linking oxytocin to menstrual migraine. Headache 61 (7) (2021)
Hsiangkuo Yuan, John G Curran, Scott W Keith, Mary M Hopkins, Stephen D Silberstein
Intravenous ibuprofen for acute treatment of migraine: A double-blind, randomized, placebo-controlled pilot study. Headache 61 (9) (2021)
Cristina Tassorelli, Hans-Christoph Diener, Stephen D Silberstein, David W Dodick, Peter J Goadsby, Rigmor H Jensen, Delphine Magis, Patricia Pozo-Rosich, Hsiangkuo Yuan, Daniele Martinelli, Thomas van den Hoek, Marie Deen, Messoud Ashina, Gisela M Terwindt
Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraine. Cephalalgia : an international journal of headache 41 (11-12) (2021)
Todd J Schwedt, Richard B Lipton, Jessica Ailani, Stephen D Silberstein, Cristina Tassorelli, Hua Guo, Kaifeng Lu, Brett Dabruzzo, Rosa Miceli, Lawrence Severt, Michelle Finnegan, Joel M Trugman
Time course of efficacy of atogepant for the preventive treatment of migraine: Results from the randomized, double-blind ADVANCE trial. Cephalalgia : an international journal of headache (2021)
David W Dodick, Anand S Shewale, Richard B Lipton, Seth J Baum, Steven C Marcus, Stephen D Silberstein, Jelena M Pavlovic, Nathan L Bennett, William B Young, Hema N Viswanathan, Jalpa A Doshi, Howard Weintraub
Migraine Patients With Cardiovascular Disease and Contraindications: An Analysis of Real-World Claims Data. Journal of primary care & community health 11 (2021)
Stephen D Silberstein, Joshua M Cohen, Michael J Seminerio, Ronghua Yang, Sait Ashina, Zaza Katsarava
The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study. The journal of headache and pain 21 (1) (2020)
Hans-Christoph Diener, Cristina Tassorelli, David W Dodick, Stephen D Silberstein, Richard B Lipton, Messoud Ashina, Werner J Becker, Michel D Ferrari, Peter J Goadsby, Patricia Pozo-Rosich, Shuu-Jiun Wang, Timothy T Houle, Thomas C van den Hoek, Daniele Martinelli, Gisela M Terwindt, null null
Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults. Cephalalgia : an international journal of headache 40 (10) (2020)
Richard B Lipton, Stewart J Tepper, Stephen D Silberstein, David Kudrow, Messoud Ashina, Uwe Reuter, David W Dodick, Feng Zhang, Gregory A Rippon, Sunfa Cheng, Daniel D Mikol
Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension. Cephalalgia : an international journal of headache 41 (1) (2020)
Stephen D Silberstein, Merle Diamond, Nada A Hindiyeh, David M Biondi, Roger Cady, Joe Hirman, Brent Allan, Susan Pederson, Barbara Schaeffler, Jeff Smith
Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy-2) study. The journal of headache and pain 21 (1) (2020)
Stephen D Silberstein, Hsiangkuo Yuan, Umer Najib, Jessica Ailani, Andreia Lopes de Morais, Paul G Mathew, Eric Liebler, Cristina Tassorelli, Hans-Christoph Diener
Non-invasive vagus nerve stimulation for primary headache: A clinical update. Cephalalgia : an international journal of headache 40 (12) (2020)
Alicia Alpuente, Cristina Tassorelli, Hans-Christoph Diener, Stephen D Silberstein, Patricia Pozo-Rosich
Have the IHS Guidelines for controlled trials of acute treatment of migraine attacks been followed? Laying the ground for the 4th edition. Cephalalgia : an international journal of headache 40 (8) (2020)
Claire Ej Ceriani, Stephen D Silberstein
Headache and rhinosinusitis: A review. Cephalalgia : an international journal of headache 41 (4) (2020)
Stewart J Tepper, Messoud Ashina, Uwe Reuter, Jan Lewis Brandes, David Doležil, Stephen D Silberstein, Paul Winner, Feng Zhang, Sunfa Cheng, Daniel D Mikol
Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study. Cephalalgia : an international journal of headache 40 (6) (2020)
Steven C Marcus, Anand R Shewale, Stephen D Silberstein, Richard B Lipton, William B Young, Hema N Viswanathan, Jalpa A Doshi
Comparison of healthcare resource utilization and costs among patients with migraine with potentially adequate and insufficient triptan response. Cephalalgia : an international journal of headache 40 (7) (2020)
Messoud Ashina, David Kudrow, Uwe Reuter, David Dolezil, Stephen D Silberstein, Stewart J Tepper, Fei Xue, Hernan Picard, Feng Zhang, Andrea Wang, Yanchen Zhou, Frank Hong, Jan Klatt, Daniel D Mikol
Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensions. Cephalalgia : an international journal of headache 39 (14) (2019)

Stephen D Silberstein.css-eqlu8i{font-size:small;padding-left:4px;} (Stephen Silberstein, Stephan D Silberstein)

Publication Activity (10 Years)

Top Topics

Top Venues

Stephen D Silberstein (Stephen Silberstein, Stephan D Silberstein)